IFCT-GFPC-1101 trial: A multicenter phase III assessing a maintenance strategy determined by response to induction chemotherapy compared to continuation maintenance with pemetrexed in patients (pts) with advanced non-squamous (NSQ) NSCLC.

M. Perol,Clarisse Audigier Valette,Olivier Molinier,Alexis B. Cortot,Jacques Margery,Lionel Moreau,Virginie Westeel,Pascal Dô,Fabrice Barlesi,Eric Pichon,Gérard Zalcman,Patrick Dumont,Nicolas Girard,M. Poudenx,Julien Mazieres,Jacques Cadranel,D. Debieuvre,Jérôme Dauba,Denis Moro-Sibilot,Pierre Jean Souquet,French Cooperative Thoracic Intergroup

IFCT-GFPC-1101 trial: A multicenter phase III assessing a maintenance strategy determined by response to induction chemotherapy compared to continuation maintenance with pemetrexed in patients (pts) with advanced non-squamous (NSQ) NSCLC.

2017

9003Background: Benefit coming from maintenance treatment appears greater for switch maintenance in pts with disease stabilization (SD) while it might be larger for continuation maintenance in pts ...

Keywords:

Pemetrexed
Physical therapy
Cancer research
Induction chemotherapy
Continuation
Medicine
in patient
Oncology
maintenance strategy
Internal medicine
non squamous
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations